APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bendamustine Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Bendamustine Injection Industry Growth and Trends Forecast to 2032

19 December 202593 pages

Choose your research edition.

Industry ResearchBendamustine Injection Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Bendamustine Injection Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Bendamustine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bendamustine Injection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Bendamustine Injection Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Bendamustine Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bendamustine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bendamustine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bendamustine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bendamustine Injection include Eagle Pharmaceuticals, Emcure, Miracalus Pharma, MundiPharma, Natco Pharma, Mylan, Teva and Eisai, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bendamustine Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bendamustine Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bendamustine Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bendamustine Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bendamustine Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bendamustine Injection Market by Company

Eagle Pharmaceuticals

Emcure

Miracalus Pharma

MundiPharma

Natco Pharma

Mylan

Teva

Eisai

Bendamustine Injection Segment by Type

25mg Injection

100mg Injection

Others

Bendamustine Injection Segment by Application

Chronic Lymphocytic Leukemia

Non-Hodgkin's Lymphoma

Multiple Myeloma

Others

Bendamustine Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bendamustine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bendamustine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bendamustine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bendamustine Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bendamustine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 25mg Injection Table 2. Major Company of 100mg Injection Table 3. Major Company of Others Table 4. Global Bendamustine Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Bendamustine Injection Sales by Type (2021-2026) & (K Units) Table 6. Global Bendamustine Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global Bendamustine Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global Bendamustine Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global Bendamustine Injection Price by Type (2021-2026) & (US$/Unit) Table 10. Global Bendamustine Injection Sales by Type (2027-2032) & (K Units) Table 11. Global Bendamustine Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global Bendamustine Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global Bendamustine Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global Bendamustine Injection Price by Type (2027-2032) & (US$/Unit) Table 15. North America Bendamustine Injection Sales by Type (2021-2026) & (K Units) Table 16. North America Bendamustine Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Bendamustine Injection Sales by Type (2021-2026) & (K Units) Table 18. Europe Bendamustine Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Bendamustine Injection Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Bendamustine Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Bendamustine Injection Sales by Type (2021-2026) & (K Units) Table 22. Latin America Bendamustine Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Bendamustine Injection Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Bendamustine Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Bendamustine Injection Industry Trends Table 26. Bendamustine Injection Industry Drivers Table 27. Bendamustine Injection Industry Opportunities and Challenges Table 28. Bendamustine Injection Industry Restraints Table 29. Global Bendamustine Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Bendamustine Injection Revenue Market Share by Company (2021-2026) Table 31. Global Bendamustine Injection Sales by Company (2021-2026) & (K Units) Table 32. Global Bendamustine Injection Sales Share by Company (2021-2026) Table 33. Global Bendamustine Injection Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Bendamustine Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Bendamustine Injection Major Company Production Sites and Headquarters Table 36. Global Bendamustine Injection Company, Product Type & Application Table 37. Global Bendamustine Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Bendamustine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Bendamustine Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Bendamustine Injection Sales by Region (2021-2026) & (K Units) Table 42. Global Bendamustine Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global Bendamustine Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global Bendamustine Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global Bendamustine Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Bendamustine Injection Sales by Region (2027-2032) & (K Units) Table 47. Global Bendamustine Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global Bendamustine Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global Bendamustine Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global Bendamustine Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Bendamustine Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Bendamustine Injection Sales by Application (2021-2026) & (K Units) Table 53. Global Bendamustine Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global Bendamustine Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global Bendamustine Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global Bendamustine Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Bendamustine Injection Sales by Application (2027-2032) & (K Units) Table 58. Global Bendamustine Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global Bendamustine Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global Bendamustine Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global Bendamustine Injection Price by Application (2027-2032) & (US$/Unit) Table 62. North America Bendamustine Injection Sales by Application (2021-2026) & (K Units) Table 63. North America Bendamustine Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Bendamustine Injection Sales by Application (2021-2026) & (K Units) Table 65. Europe Bendamustine Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Bendamustine Injection Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Bendamustine Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Bendamustine Injection Sales by Application (2021-2026) & (K Units) Table 69. Latin America Bendamustine Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Bendamustine Injection Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Bendamustine Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Eagle Pharmaceuticals Company Information Table 73. Eagle Pharmaceuticals Business Overview Table 74. Eagle Pharmaceuticals Bendamustine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Eagle Pharmaceuticals Bendamustine Injection Product Portfolio Table 76. Eagle Pharmaceuticals Recent Development Table 77. Emcure Company Information Table 78. Emcure Business Overview Table 79. Emcure Bendamustine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Emcure Bendamustine Injection Product Portfolio Table 81. Emcure Recent Development Table 82. Miracalus Pharma Company Information Table 83. Miracalus Pharma Business Overview Table 84. Miracalus Pharma Bendamustine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Miracalus Pharma Bendamustine Injection Product Portfolio Table 86. Miracalus Pharma Recent Development Table 87. MundiPharma Company Information Table 88. MundiPharma Business Overview Table 89. MundiPharma Bendamustine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. MundiPharma Bendamustine Injection Product Portfolio Table 91. MundiPharma Recent Development Table 92. Natco Pharma Company Information Table 93. Natco Pharma Business Overview Table 94. Natco Pharma Bendamustine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Natco Pharma Bendamustine Injection Product Portfolio Table 96. Natco Pharma Recent Development Table 97. Mylan Company Information Table 98. Mylan Business Overview Table 99. Mylan Bendamustine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Mylan Bendamustine Injection Product Portfolio Table 101. Mylan Recent Development Table 102. Teva Company Information Table 103. Teva Business Overview Table 104. Teva Bendamustine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Teva Bendamustine Injection Product Portfolio Table 106. Teva Recent Development Table 107. Eisai Company Information Table 108. Eisai Business Overview Table 109. Eisai Bendamustine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Eisai Bendamustine Injection Product Portfolio Table 111. Eisai Recent Development Table 112. North America Bendamustine Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. North America Bendamustine Injection Sales by Country (2021-2026) & (K Units) Table 114. North America Bendamustine Injection Sales Market Share by Country (2021-2026) Table 115. North America Bendamustine Injection Sales Forecast by Country (2027-2032) & (K Units) Table 116. North America Bendamustine Injection Sales Market Share Forecast by Country (2027-2032) Table 117. North America Bendamustine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Bendamustine Injection Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Bendamustine Injection Market Share by Country (2021-2026) Table 120. North America Bendamustine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Bendamustine Injection Market Share Forecast by Country (2027-2032) Table 122. Europe Bendamustine Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Europe Bendamustine Injection Sales by Country (2021-2026) & (K Units) Table 124. Europe Bendamustine Injection Sales Market Share by Country (2021-2026) Table 125. Europe Bendamustine Injection Sales Forecast by Country (2027-2032) & (K Units) Table 126. Europe Bendamustine Injection Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Bendamustine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Bendamustine Injection Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Bendamustine Injection Market Share by Country (2021-2026) Table 130. Europe Bendamustine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Bendamustine Injection Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Bendamustine Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Bendamustine Injection Sales by Country (2021-2026) & (K Units) Table 134. Asia-Pacific Bendamustine Injection Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Bendamustine Injection Sales Forecast by Country (2027-2032) & (K Units) Table 136. Asia-Pacific Bendamustine Injection Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Bendamustine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Bendamustine Injection Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Bendamustine Injection Market Share by Country (2021-2026) Table 140. Asia-Pacific Bendamustine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Bendamustine Injection Market Share Forecast by Country (2027-2032) Table 142. Latin America Bendamustine Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Latin America Bendamustine Injection Sales by Country (2021-2026) & (K Units) Table 144. Latin America Bendamustine Injection Sales Market Share by Country (2021-2026) Table 145. Latin America Bendamustine Injection Sales Forecast by Country (2027-2032) & (K Units) Table 146. Latin America Bendamustine Injection Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Bendamustine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Bendamustine Injection Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Bendamustine Injection Market Share by Country (2021-2026) Table 150. Latin America Bendamustine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Bendamustine Injection Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Bendamustine Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Bendamustine Injection Sales by Country (2021-2026) & (K Units) Table 154. Middle East and Africa Bendamustine Injection Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Bendamustine Injection Sales Forecast by Country (2027-2032) & (K Units) Table 156. Middle East and Africa Bendamustine Injection Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Bendamustine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Bendamustine Injection Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Bendamustine Injection Market Share by Country (2021-2026) Table 160. Middle East and Africa Bendamustine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Bendamustine Injection Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Bendamustine Injection Distributors List Table 165. Bendamustine Injection Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Bendamustine Injection Image Figure 2. Global Bendamustine Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bendamustine Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Bendamustine Injection Sales (2021-2032) & (K Units) Figure 5. 25mg Injection Image Figure 6. Global 25mg Injection Sales YoY Growth (2021-2032) & (K Units) Figure 7. 100mg Injection Image Figure 8. Global 100mg Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Bendamustine Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Bendamustine Injection Market Share by Type 2025 VS 2032 Figure 13. North America Bendamustine Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America Bendamustine Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe Bendamustine Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe Bendamustine Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Bendamustine Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Bendamustine Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America Bendamustine Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Bendamustine Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Bendamustine Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Bendamustine Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Bendamustine Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Chronic Lymphocytic Leukemia Image Figure 26. Global Chronic Lymphocytic Leukemia Sales YoY Growth (2021-2032) & (K Units) Figure 27. Non-Hodgkin's Lymphoma Image Figure 28. Global Non-Hodgkin's Lymphoma Sales YoY Growth (2021-2032) & (K Units) Figure 29. Multiple Myeloma Image Figure 30. Global Multiple Myeloma Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Bendamustine Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Bendamustine Injection Market Share by Application 2025 VS 2032 Figure 35. North America Bendamustine Injection Sales Market Share in Volume by Application in 2025 Figure 36. North America Bendamustine Injection Sales Market Share in Value by Application in 2025 Figure 37. Europe Bendamustine Injection Sales Market Share in Volume by Application in 2025 Figure 38. Europe Bendamustine Injection Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Bendamustine Injection Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Bendamustine Injection Sales Market Share in Value by Application in 2025 Figure 41. Latin America Bendamustine Injection Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Bendamustine Injection Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Bendamustine Injection Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Bendamustine Injection Sales Market Share in Value by Application in 2025 Figure 45. North America Bendamustine Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Bendamustine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Bendamustine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Bendamustine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Bendamustine Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Bendamustine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Bendamustine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Bendamustine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Bendamustine Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Bendamustine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Bendamustine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Bendamustine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Bendamustine Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Bendamustine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Bendamustine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Bendamustine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Bendamustine Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Bendamustine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Bendamustine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Bendamustine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Bendamustine Injection Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Bendamustine Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 25mg Injection
  • 100mg Injection
  • Others
Applications
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin's Lymphoma
  • Multiple Myeloma
  • Others
Companies covered
  • Eagle Pharmaceuticals
  • Emcure
  • Miracalus Pharma
  • MundiPharma
  • Natco Pharma
  • Mylan
  • Teva
  • Eisai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bendamustine Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bendamustine Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bendamustine Injection Market by Type
  6. 1.3.1 25mg Injection
  7. 1.3.2 100mg Injection
  8. 1.3.3 Others
  9. 1.4 Global Bendamustine Injection Market Size by Type
  10. 1.4.1 Global Bendamustine Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Bendamustine Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Bendamustine Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Bendamustine Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Bendamustine Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Bendamustine Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Bendamustine Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Bendamustine Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bendamustine Injection Industry Trends
  2. 2.2 Bendamustine Injection Industry Drivers
  3. 2.3 Bendamustine Injection Industry Opportunities and Challenges
  4. 2.4 Bendamustine Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bendamustine Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Bendamustine Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Bendamustine Injection Price (2021-2026)
  4. 3.4 Global Bendamustine Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bendamustine Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Bendamustine Injection Company, Product Type & Application
  7. 3.7 Global Bendamustine Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bendamustine Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bendamustine Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bendamustine Injection Tier 1, Tier 2, and Tier 3
4 Bendamustine Injection Regional Status and Outlook
  1. 4.1 Global Bendamustine Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bendamustine Injection Historic Market Size by Region
  3. 4.2.1 Global Bendamustine Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bendamustine Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bendamustine Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bendamustine Injection Forecasted Market Size by Region
  7. 4.3.1 Global Bendamustine Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bendamustine Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bendamustine Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bendamustine Injection by Application
  1. 5.1 Bendamustine Injection Market by Application
  2. 5.1.1 Chronic Lymphocytic Leukemia
  3. 5.1.2 Non-Hodgkin's Lymphoma
  4. 5.1.3 Multiple Myeloma
  5. 5.1.4 Others
  6. 5.2 Global Bendamustine Injection Market Size by Application
  7. 5.2.1 Global Bendamustine Injection Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Bendamustine Injection Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Bendamustine Injection Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Bendamustine Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Bendamustine Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Bendamustine Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Bendamustine Injection Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Bendamustine Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eagle Pharmaceuticals
  2. 6.1.1 Eagle Pharmaceuticals Company Information
  3. 6.1.2 Eagle Pharmaceuticals Business Overview
  4. 6.1.3 Eagle Pharmaceuticals Bendamustine Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eagle Pharmaceuticals Bendamustine Injection Product Portfolio
  6. 6.1.5 Eagle Pharmaceuticals Recent Developments
  7. 6.2 Emcure
  8. 6.2.1 Emcure Company Information
  9. 6.2.2 Emcure Business Overview
  10. 6.2.3 Emcure Bendamustine Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Emcure Bendamustine Injection Product Portfolio
  12. 6.2.5 Emcure Recent Developments
  13. 6.3 Miracalus Pharma
  14. 6.3.1 Miracalus Pharma Company Information
  15. 6.3.2 Miracalus Pharma Business Overview
  16. 6.3.3 Miracalus Pharma Bendamustine Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Miracalus Pharma Bendamustine Injection Product Portfolio
  18. 6.3.5 Miracalus Pharma Recent Developments
  19. 6.4 MundiPharma
  20. 6.4.1 MundiPharma Company Information
  21. 6.4.2 MundiPharma Business Overview
  22. 6.4.3 MundiPharma Bendamustine Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 MundiPharma Bendamustine Injection Product Portfolio
  24. 6.4.5 MundiPharma Recent Developments
  25. 6.5 Natco Pharma
  26. 6.5.1 Natco Pharma Company Information
  27. 6.5.2 Natco Pharma Business Overview
  28. 6.5.3 Natco Pharma Bendamustine Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Natco Pharma Bendamustine Injection Product Portfolio
  30. 6.5.5 Natco Pharma Recent Developments
  31. 6.6 Mylan
  32. 6.6.1 Mylan Company Information
  33. 6.6.2 Mylan Business Overview
  34. 6.6.3 Mylan Bendamustine Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mylan Bendamustine Injection Product Portfolio
  36. 6.6.5 Mylan Recent Developments
  37. 6.7 Teva
  38. 6.7.1 Teva Company Information
  39. 6.7.2 Teva Business Overview
  40. 6.7.3 Teva Bendamustine Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Teva Bendamustine Injection Product Portfolio
  42. 6.7.5 Teva Recent Developments
  43. 6.8 Eisai
  44. 6.8.1 Eisai Company Information
  45. 6.8.2 Eisai Business Overview
  46. 6.8.3 Eisai Bendamustine Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Eisai Bendamustine Injection Product Portfolio
  48. 6.8.5 Eisai Recent Developments
7 North America by Country
  1. 7.1 North America Bendamustine Injection Sales by Country
  2. 7.1.1 North America Bendamustine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bendamustine Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Bendamustine Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bendamustine Injection Market Size by Country
  6. 7.2.1 North America Bendamustine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bendamustine Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Bendamustine Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bendamustine Injection Sales by Country
  2. 8.1.1 Europe Bendamustine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bendamustine Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Bendamustine Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bendamustine Injection Market Size by Country
  6. 8.2.1 Europe Bendamustine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bendamustine Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bendamustine Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bendamustine Injection Sales by Country
  2. 9.1.1 Asia-Pacific Bendamustine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bendamustine Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bendamustine Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bendamustine Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Bendamustine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bendamustine Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bendamustine Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bendamustine Injection Sales by Country
  2. 10.1.1 South America Bendamustine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bendamustine Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Bendamustine Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bendamustine Injection Market Size by Country
  6. 10.2.1 South America Bendamustine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bendamustine Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Bendamustine Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bendamustine Injection Sales by Country
  2. 11.1.1 Middle East and Africa Bendamustine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bendamustine Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bendamustine Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bendamustine Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Bendamustine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bendamustine Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bendamustine Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bendamustine Injection Value Chain Analysis
  2. 12.1.1 Bendamustine Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bendamustine Injection Production Mode & Process
  7. 12.2 Bendamustine Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bendamustine Injection Distributors
  10. 12.2.3 Bendamustine Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst